Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.PCAD.2019.11.010 | ||||
| Año | 2020 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Purpose: Whether physical activity (PA) might have certain benefits for cardiovascular disease (CVD) primordial prevention even in the absence of clinically significant weight loss is of public health interest. In this study, we examined the independent and combined associations of simultaneous changes in PA and body weight with the subsequent development of major CVD risk factors in adults. Methods: This prospective analysis included 116,134 healthy men and women, aged ≥18 years, with at least 3 medical examinations from the Taiwan MJ Cohort. Two-year changes in PA and body weight between the first and second examination were linked to subsequent development of hypertension, hypercholesterolemia, atherogenic dyslipidemia, metabolic syndrome, type 2 diabetes mellitus (T2DM), and chronic inflammation, which were assessed by physical examinations and laboratory tests. Results: During an average follow-up of 5.7 ± 4.1 years after the second examination, 10,840 individuals developed hypertension, 10,888 hypercholesterolemia, 6078 atherogenic dyslipidemia, 13,223 metabolic syndrome, 4816 T2DM, and 2027 inflammation. Weight gain was associated with a subsequent higher risk of all CVD risk factors, with HR (95%CI) ranging from 1.11 (1.00–1.23) for inflammation to 1.74 (1.67–1.82) for metabolic syndrome, compared with participants who lost weight. A stable weight was also associated with a higher risk of all CVD risk factors except with inflammation. In combined analyses, participants who simultaneously gained weight and decreased PA levels had the highest risk compared with those who lost weight and increased PA. Increasing or maintaining PA reduced the increased subsequent risk of some CVD risk factors among participants who maintained a stable weight or gained weight. Among participants who lost weight, decreased PA was not associated with an increased risk. Conclusions: Although weight loss is crucial for the prevention of CVD risk factors, increasing or maintaining PA is also important to prevent them among adults who gain or maintain their weight.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Martinez-Gomez, David | Hombre |
Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
IMDEA Food Institute - España UNIV AUTONOMA MADRID - España CEI UAM CSIC - España Universidad Autónoma de Madrid - España |
| 2 | Lavie, Carl J. | Hombre |
University of Queensland - Australia
The University of Queensland - Australia UNIV QUEENSLAND - Estados Unidos The University of Queensland - Estados Unidos |
| 3 | Hamer, Mark | Hombre |
UCL - Reino Unido
University College London - Reino Unido |
| 4 | Cabanas-Sanchez, Veronica | Mujer |
IMDEA Food Institute - España
CEI UAM CSIC - España |
| 5 | Garcia-Esquinas, Esther | Mujer |
Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
UNIV AUTONOMA MADRID - España Universidad Autónoma de Madrid - España |
| 6 | Pareja-Galeano, Helios | - |
Universidad Europea de Madrid - España
Univ Europea Madrid - España |
| 7 | Struijk, Ellen | Mujer |
Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
UNIV AUTONOMA MADRID - España Universidad Autónoma de Madrid - España |
| 8 | Sadarangani, Kabir P. | Hombre |
Universidad San Sebastián - Chile
Universidad Diego Portales - Chile |
| 9 | Ortega, Francisco B. | Hombre |
Universidad de Granada - España
NOVUM - Suecia UNIV GRANADA - España Karolinska Inst - Suecia Karolinska Institutet - Suecia |
| 10 | Rodriguez-Artalejo, Fernando | Hombre |
Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
IMDEA Food Institute - España UNIV AUTONOMA MADRID - España CEI UAM CSIC - España Universidad Autónoma de Madrid - España |
| Fuente |
|---|
| MJ Health Research Center |
| Plan Nacional sobre Drogas (Ministry of Health of Spain) |
| MJ Health Management Institution |
| FIS |
| 'Ramon y Cajal' contract |
| Ministry of Health of Spain |
| Health Research Center |
| MINECO R+D+I |
| R+D+I |
| Plan Nacional sobre Drogas |
| MJ Health Research Foundation |
| MINECO R+D+ I grant |
| MJ Health Research Foundation by MJ Health Research Center |
| Agradecimiento |
|---|
| This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
| This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+ I grant (DEP2013-47786-R). DM -G is supported by a 'Ramon y Cajal' contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
| This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
| This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |